Houlihan Lokey (HLI) Stock Forecast, Price & News

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Houlihan Lokey in the last twelve months. There are currently 1 sell rating, 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" HLI shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in HLI, but not buy additional shares or sell existing shares.
View HLI analyst ratings or view top-rated stocks.

4 Wall Street research analysts have issued 12 month target prices for Houlihan Lokey's stock. Their HLI share price forecasts range from $78.00 to $102.00. On average, they anticipate the company's stock price to reach $88.25 in the next twelve months. This suggests that the stock has a possible downside of 2.1%.
View analysts price targets for HLI or view top-rated stocks among Wall Street analysts.

Houlihan Lokey's stock was trading at $87.16 on January 1st, 2023. Since then, HLI stock has increased by 3.4% and is now trading at $90.16.
View the best growth stocks for 2023 here.

Houlihan Lokey saw a increase in short interest during the month of May. As of May 15th, there was short interest totaling 1,940,000 shares, an increase of 6.0% from the April 30th total of 1,830,000 shares. Based on an average daily volume of 462,000 shares, the days-to-cover ratio is presently 4.2 days. Currently, 3.9% of the company's stock are sold short.
View Houlihan Lokey's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Thursday, July 27th 2023.
View our HLI earnings forecast.

Houlihan Lokey, Inc. (NYSE:HLI) released its quarterly earnings results on Tuesday, May, 9th. The financial services provider reported $1.11 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.88 by $0.23. The financial services provider earned $444.77 million during the quarter, compared to analysts' expectations of $423.96 million. Houlihan Lokey had a trailing twelve-month return on equity of 20.96% and a net margin of 14.88%. Houlihan Lokey's quarterly revenue was down 5.6% on a year-over-year basis. During the same period last year, the company posted $1.30 earnings per share.

Houlihan Lokey announced a quarterly dividend on Tuesday, May 9th. Stockholders of record on Friday, June 2nd will be paid a dividend of $0.55 per share on Thursday, June 15th. This represents a $2.20 annualized dividend and a yield of 2.44%. The ex-dividend date of this dividend is Thursday, June 1st. This is a positive change from the stock's previous quarterly dividend of $0.53.
Read our dividend analysis for HLI.

ETFs with the largest weight of Houlihan Lokey (NYSE:HLI) stock in their portfolio include Argent Mid Cap ETF (AMID), iShares U.S. Broker-Dealers & Securities Exchanges ETF (IAI), ALPS O'Shares U.S. Small-Cap Quality Dividend ETF (OUSM), Invesco DWA Financial Momentum ETF (PFI), SPDR S&P Capital Markets ETF (KCE), AB US Low Volatility Equity ETF (LOWV), Franklin U.S. Small Cap Multifactor Index ETF (FLQS) and Invesco Russell 2000 Dynamic Multifactor ETF (OMFS).

Houlihan Lokey (NYSE:HLI) pays an annual dividend of $2.12 per share and currently has a dividend yield of 2.43%. The company has been increasing its dividend for 9 consecutive years, indicating the company has a new, but growing committment to grow its dividend. The dividend payout ratio is 54.36%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, HLI will have a dividend payout ratio of 35.45% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for HLI.

77 employees have rated Houlihan Lokey Chief Executive Officer Scott Beiser on Glassdoor.com. Scott Beiser has an approval rating of 87% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Houlihan Lokey investors own include Energy Transfer (ET), AT&T (T), CVS Health (CVS), Home Depot (HD), Pfizer (PFE), Johnson & Johnson (JNJ), Verizon Communications (VZ), Alibaba Group (BABA) and Cisco Systems (CSCO).

(HLI) raised $301 million in an initial public offering (IPO) on Thursday, August 13th 2015. The company issued 13,100,000 shares at a price of $22.00-$24.00 per share. BofA Merrill Lynch and Goldman Sachs acted as the underwriters for the IPO and UBS Investment Bank, Keefe, Bruyette & Woods (A Stifel Company), Houlihan Lokey, Sandler O'Neill + Partners and JMP Securities were co-managers.

Houlihan Lokey trades on the New York Stock Exchange (NYSE) under the ticker symbol "HLI."

Houlihan Lokey's stock is owned by many different retail and institutional investors. Top institutional investors include BlackRock Inc. (5.85%), Kayne Anderson Rudnick Investment Management LLC (3.93%), Burgundy Asset Management Ltd. (2.32%), Bank of America Corp DE (2.05%), Clearbridge Investments LLC (1.71%) and State Street Corp (1.63%). Insiders that own company stock include Irwin Gold, J Lindsey Alley, Paul Andrew Zuber, Robert A Schriesheim, Robert A Schriesheim, Scott Joseph Adelson, Scott L Beiser and Scott L Beiser.
View institutional ownership trends.

Shares of HLI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of HLI stock can currently be purchased for approximately $90.16.

Houlihan Lokey (NYSE:HLI) has a market capitalization of $6.19 billion and generates $1.81 billion in revenue each year. The financial services provider earns $254.22 million in net income (profit) each year or $3.90 on an earnings per share basis.

The company employs 1,574 workers across the globe.

Houlihan Lokey's mailing address is 10250 CONSTELLATION BLVD. 5TH FLOOR, LOS ANGELES CA, 90067. The official website for the company is www.hl.com. The financial services provider can be reached via phone at (310) 788-5200, via email at ir@hl.com, or via fax at 310-553-2173.